Great Ormond Street Hospital, London, UK.
Arthritis Care Res (Hoboken). 2012 Nov;64(11):1665-72. doi: 10.1002/acr.21753.
To compare 2 groups of children with juvenile dermatomyositis (DM), those with onset of symptoms before their fifth birthday versus those whose disease begins either on or after their fifth birthday, and to assess whether age at onset is associated with differences in disease presentation, treatments received, or outcomes 2 years after diagnosis.
Data were analyzed on children recruited to a UK juvenile DM cohort study with a diagnosis of probable or definite juvenile DM and less than 12 months between diagnosis and recruitment.
Fifty-five (35%) of 157 children had onset of symptoms before their fifth birthday. At diagnosis, cutaneous ulceration was found in 32.7% of the younger group versus 11.8% of the older group (P = 0.003). Facial or body swelling was reported more often in the younger group, whereas headaches, alopecia, and Raynaud's phenomenon were all more frequently reported in the older group. At followup 2 years later, there were no important differences in outcomes between the groups. More than 90% of patients in both groups received both methotrexate and steroids. Twenty-three percent of both groups remained on steroids 2 years after diagnosis.
Our study showed that children with juvenile DM with disease onset at age <5 years are more likely to present with ulcerative skin disease and edema. There were no clinically significant differences in outcomes between the 2 groups.
比较两组幼年皮肌炎(DM)患儿,一组发病年龄在 5 岁前,另一组发病年龄在 5 岁或 5 岁后,评估发病年龄是否与疾病表现、治疗方法或诊断后 2 年的预后存在差异。
对英国幼年 DM 队列研究中招募的确诊为可能或明确的幼年 DM 且诊断与招募之间时间间隔小于 12 个月的患儿进行数据分析。
157 例患儿中 55 例(35%)发病年龄小于 5 岁。诊断时,<5 岁组皮肤溃疡发生率为 32.7%,而≥5 岁组为 11.8%(P=0.003)。<5 岁组更常报告面部或全身肿胀,而≥5 岁组更常报告头痛、脱发和雷诺现象。2 年后随访时,两组患儿的预后无显著差异。两组患儿均有超过 90%接受了甲氨蝶呤和皮质类固醇治疗。23%的患儿在诊断后 2 年仍在使用皮质类固醇。
本研究表明,发病年龄<5 岁的幼年 DM 患儿更易出现溃疡性皮肤疾病和水肿。两组患儿的预后无显著差异。